Safety and Pharmacokinetics of Sustained-release Depot Tacrolimus: A First-in-human Study

Conditions:   Organ Transplant Rejection;   Psoriasis Intervention:   Drug: Sustained Release Injectable Tacrolimus Sponsors:   Auritec Pharmaceuticals;   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials